Administration of perilla oil coated with Calshell increases glucagon-like peptide secretion

被引:7
作者
Adachi, Tetsuya [1 ]
Yanaka, Hiroyuki [2 ]
Kanai, Hitoshi [2 ]
Nozaki, Mayu [2 ]
Takahara, Yoshiyuki [3 ]
Tsuda, Mariko [4 ]
Jonouchi, Tatsuya [1 ]
Tsuda, Kinsuke [4 ]
Hirasawa, Akira [1 ]
Tsujimoto, Gozoh [1 ]
机构
[1] Kyoto Univ, Dept Genom Drug Discovery Sci, Grad Sch Pharmaceut Sci, Sakyo Ku, Kyoto 6068501, Japan
[2] Kyoto Univ, Lab Metab, Grad Sch Human & Environm Sci, Sakyo Ku, Kyoto 6068501, Japan
[3] KITII Co Ltd, Saiwai Ku, Kawasaki, Kanagawa 2120054, Japan
[4] Pharma Frontier Co Ltd, Nakagyo Ku, Kyoto 6040804, Japan
关键词
Calshell; perilla oil; glucagon-like peptide-1; insulin; moose;
D O I
10.1248/bpb.31.1021
中图分类号
R9 [药学];
学科分类号
1007 [药学];
摘要
Recently, we found that unsaturated long-chain fatty acids (such as a-linolenic acid) promote the secretion of glucagon-like peptide-1 (GLP-1) via G protein-coupled receptor GPR120, which is expressed predominantly in the colon. In order to ensure that the triglycerides or free fatty acids, such as a-linolenic acid, reach the distal intestinal tract effectively, we developed a Calshell technique. Following single treatment of Calshell perilla oil powder, the GLP-1 secretion level was significantly higher than following vehicle treatment, 120 min after treatment. Next, we examined the effects of long-term Calshell perilla oil powder treatment on GLP-1 secretion. Plasma GLP-1 level of Calshell perilla oil powder treatment was significantly higher than of vehicle treatment for 1, 14, 28 and 56 d. We thereby demonstrated for the first time the utility of Calshell oil powder treatment for effective and sustainable GLP-1 secretion. The Calshell technique is apparently useful as a drug delivery system, since Calshell unsaturated oil powder is protected from gastric acid, reaches enteroendocrine cells in the gastrointestinal tract, and then induces effective incretin secretion.
引用
收藏
页码:1021 / 1023
页数:3
相关论文
共 26 条
[1]
Free fatty acids administered into the colon promote the secretion of glucagon-like peptide-1 and insulin [J].
Adachi, T ;
Tanaka, T ;
Takemoto, K ;
Koshimizu, TA ;
Hirasawa, A ;
Tsujimoto, G .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2006, 340 (01) :332-337
[2]
Peptide YY, glucagon-like peptide-1, and neurotensin responses to luminal factors in the isolated vascularly perfused rat ileum [J].
Dumoulin, V ;
Moro, F ;
Barcelo, A ;
Dakka, T ;
Cuber, JC .
ENDOCRINOLOGY, 1998, 139 (09) :3780-3786
[3]
Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120 [J].
Hirasawa, A ;
Tsumaya, K ;
Awaji, T ;
Katsuma, S ;
Adachi, T ;
Yamada, M ;
Sugimoto, Y ;
Miyazaki, S ;
Tsujimoto, G .
NATURE MEDICINE, 2005, 11 (01) :90-94
[4]
Comparative effects of perilla and fish oils on the activity and gene expression of fatty acid oxidation enzymes in rat liver [J].
Ide, T ;
Kobayashi, H ;
Ashakumary, L ;
Rouyer, IA ;
Takahashi, Y ;
Aoyama, T ;
Hashimoto, T ;
Mizugaki, M .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2000, 1485 (01) :23-35
[5]
Reduced hepatic triglyceride secretion in rats fed docosahexaenoic acid-rich fish oil suppresses postprandial hypertriglyceridemia [J].
Ikeda, I ;
Kumamaru, J ;
Nakatani, N ;
Sakono, M ;
Murota, I ;
Imaizumi, K .
JOURNAL OF NUTRITION, 2001, 131 (04) :1159-1164
[6]
Comparison of the subchronic antidiabetic effects of DPP IV-resistant GIP and GLP-1 analogues in obese diabetic (ob/ob) mice [J].
Irwin, Nigel ;
McClean, Paula L. ;
Flatt, Peter R. .
JOURNAL OF PEPTIDE SCIENCE, 2007, 13 (06) :400-405
[7]
Jain A, 2007, J PHARM PHARM SCI, V10, P86
[8]
Potential of calcium pectinate beads for target specific drug release to colon [J].
Jain, Anekant ;
Gupta, Yashwant ;
Jain, Sanjay K. .
JOURNAL OF DRUG TARGETING, 2007, 15 (04) :285-294
[9]
Activity of hepatic fatty acid oxidation enzymes in rats fed alpha-linolenic acid [J].
Kabir, Y ;
Ide, T .
BIOCHIMICA ET BIOPHYSICA ACTA-LIPIDS AND LIPID METABOLISM, 1996, 1304 (02) :105-119
[10]
Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease [J].
Kris-Etherton, PM ;
Harris, WS ;
Appel, LJ .
CIRCULATION, 2002, 106 (21) :2747-2757